New Market Research Report: Romania Pharmaceuticals & Healthcare Report Q2 2014
Romania's pharmaceutical market will post moderate growth over the short term due to continued focus on price controls, limited reimbursement of pharmaceuticals and stubbornly high unemployment levels. Unemployment levels and the state of Romania's economy directly impact revenues for the state insurer; while the country's economic picture in early 2014 is improving, the benefits will not be felt until the medium term. These issues continue to weigh down our assessment of the Romanian pharmaceutical and healthcare market in Q214.
View full press release